Halozyme Therapeutics, Inc. (HALO)
USD 46.84
(-3.62%)
USD 46.84
(-3.62%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.49 Billion USD | -0.45% |
| 2022 | 1.5 Billion USD | 71.8% |
| 2021 | 876.67 Million USD | 120.7% |
| 2020 | 397.22 Million USD | -1.33% |
| 2019 | 402.58 Million USD | 218.55% |
| 2018 | 126.38 Million USD | -37.54% |
| 2017 | 202.35 Million USD | -6.59% |
| 2016 | 216.62 Million USD | 334.69% |
| 2015 | 49.83 Million USD | -0.05% |
| 2014 | 49.86 Million USD | 0.18% |
| 2013 | 49.77 Million USD | 59.98% |
| 2012 | 31.11 Million USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 400 Thousand USD | 0.0% |
| 2001 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.53 Billion USD | 0.04% |
| 2024 Q1 | 1.53 Billion USD | 2.23% |
| 2024 Q3 | 1.5 Billion USD | -1.89% |
| 2023 Q2 | 1.49 Billion USD | 0.11% |
| 2023 Q1 | 1.49 Billion USD | -0.78% |
| 2023 Q4 | 1.49 Billion USD | 0.11% |
| 2023 FY | 1.49 Billion USD | -0.45% |
| 2023 Q3 | 1.49 Billion USD | 0.11% |
| 2022 Q1 | 877.64 Million USD | 0.11% |
| 2022 Q3 | 1.5 Billion USD | 20.73% |
| 2022 FY | 1.5 Billion USD | 71.8% |
| 2022 Q2 | 1.24 Billion USD | 41.99% |
| 2022 Q4 | 1.5 Billion USD | 0.11% |
| 2021 Q2 | 874.73 Million USD | 0.11% |
| 2021 Q1 | 873.77 Million USD | 119.97% |
| 2021 Q3 | 875.7 Million USD | 0.11% |
| 2021 Q4 | 876.67 Million USD | 0.11% |
| 2021 FY | 876.67 Million USD | 120.7% |
| 2020 Q3 | 393.63 Million USD | 0.91% |
| 2020 Q4 | 397.22 Million USD | 0.91% |
| 2020 FY | 397.22 Million USD | -1.33% |
| 2020 Q1 | 389.43 Million USD | -3.27% |
| 2020 Q2 | 390.07 Million USD | 0.17% |
| 2019 FY | 402.58 Million USD | 218.55% |
| 2019 Q1 | 105.4 Million USD | -16.6% |
| 2019 Q2 | 84.96 Million USD | -19.4% |
| 2019 Q3 | 63.84 Million USD | -24.85% |
| 2019 Q4 | 402.58 Million USD | 530.57% |
| 2018 FY | 126.38 Million USD | -37.54% |
| 2018 Q3 | 146.46 Million USD | -11.79% |
| 2018 Q4 | 126.38 Million USD | -13.71% |
| 2018 Q2 | 166.04 Million USD | -10.32% |
| 2018 Q1 | 185.15 Million USD | -8.5% |
| 2017 Q4 | 202.35 Million USD | -2.18% |
| 2017 Q2 | 211.03 Million USD | -1.4% |
| 2017 Q1 | 214.03 Million USD | -1.2% |
| 2017 Q3 | 206.85 Million USD | -1.98% |
| 2017 FY | 202.35 Million USD | -6.59% |
| 2016 Q4 | 216.62 Million USD | 2.08% |
| 2016 FY | 216.62 Million USD | 334.69% |
| 2016 Q2 | 208.13 Million USD | 6.18% |
| 2016 Q3 | 212.19 Million USD | 1.95% |
| 2016 Q1 | 196.01 Million USD | 293.35% |
| 2015 Q2 | 49.75 Million USD | 0.08% |
| 2015 FY | 49.83 Million USD | -0.05% |
| 2015 Q1 | 49.71 Million USD | -0.29% |
| 2015 Q4 | 49.83 Million USD | 0.08% |
| 2015 Q3 | 49.79 Million USD | 0.08% |
| 2014 Q4 | 49.86 Million USD | 0.05% |
| 2014 Q3 | 49.83 Million USD | 0.04% |
| 2014 Q2 | 49.81 Million USD | 0.05% |
| 2014 Q1 | 49.79 Million USD | 0.04% |
| 2014 FY | 49.86 Million USD | 0.18% |
| 2013 Q4 | 49.77 Million USD | 54.08% |
| 2013 Q3 | 32.3 Million USD | 1.52% |
| 2013 Q2 | 31.81 Million USD | 2.19% |
| 2013 Q1 | 31.13 Million USD | 0.08% |
| 2013 FY | 49.77 Million USD | 59.98% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | 31.11 Million USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | 31.11 Million USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q2 | - USD | -100.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q1 | 135.93 Million USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | - USD | -100.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 FY | 400 Thousand USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -553.461% |
| IO Biotech, Inc. | 2.49 Million USD | -60014.194% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -700483.178% |
| Organovo Holdings, Inc. | 1.39 Million USD | -107450.072% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -3067728.934% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -914259.597% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -15178.182% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -21244.647% |
| Savara Inc. | 26.73 Million USD | -5507.181% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -222010.815% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -5886.934% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -7078.851% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -17320232.717% |
| Soligenix, Inc. | 3.49 Million USD | -42802.327% |
| Aptose Biosciences Inc. | 1 Million USD | -148368.914% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -7425.968% |
| Century Therapeutics, Inc. | 48.17 Million USD | -3012.346% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -3483.032% |
| Precision BioSciences, Inc. | 31.26 Million USD | -4694.832% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -704.438% |
| Kura Oncology, Inc. | 17.2 Million USD | -8616.558% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Dyadic International, Inc. | 136.92 Thousand USD | -1094809.04% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -1521.983% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -52102.228% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -10628.839% |
| Autolus Therapeutics plc | 52.96 Million USD | -2730.532% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -27383.923% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -27313.567% |
| GRI Bio, Inc. | 14 Thousand USD | -10708814.286% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -11967.354% |
| IGM Biosciences, Inc. | 40.5 Million USD | -3601.299% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -734.64% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -25280.617% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -181221.749% |
| Opthea Limited | 200.62 Million USD | -647.275% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -2472.447% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -2490.628% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -13083.679% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -24218.702% |
| Surrozen, Inc. | 3.37 Million USD | -44269.577% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 3.13 Million USD | -47721.393% |
| Ovid Therapeutics Inc. | 46 Million USD | -3159.113% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -1014.649% |
| Acelyrin, Inc. | 1.19 Million USD | -125465.159% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -1672.412% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -717174.902% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -4861.769% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -2315.22% |
| ADMA Biologics, Inc. | 141.41 Million USD | -960.154% |
| PureTech Health plc | 25.51 Million USD | -5776.638% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -471361.635% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -85718.432% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -11454.008% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -1670.612% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -606882.996% |
| ChromaDex Corporation | 3.27 Million USD | -45650.626% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -240935.493% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -689.311% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -1339.066% |
| Better Therapeutics, Inc. | 14.88 Million USD | -9975.591% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -4797.263% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -1251.551% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -3834.621% |
| Seer, Inc. | 28.25 Million USD | -5205.382% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -24357.553% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -23648.582% |
| Gritstone bio, Inc. | 104.77 Million USD | -1330.921% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -53713.64% |
| Avid Bioservices, Inc. | 207.83 Million USD | -621.368% |
| Insmed Incorporated | 1.2 Billion USD | -24.523% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -28764.998% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -38312.708% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -1348.045% |
| MediWound Ltd. | 6.71 Million USD | -22240.158% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -1378.782% |
| Fortress Biotech, Inc. | 88.59 Million USD | -1592.306% |
| OmniAb, Inc. | 25.56 Million USD | -5765.373% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -600.793% |
| Zai Lab Limited | 15.15 Million USD | -9795.373% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -213.366% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -4624.72% |
| Veracyte, Inc. | 12.63 Million USD | -11770.53% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -27663.852% |
| FibroGen, Inc. | 170.45 Million USD | -779.556% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -73609.377% |
| ContextLogic Inc. | 6 Million USD | -24887.467% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -948791.139% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -22757.875% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 74.136% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -2097.344% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -4051921.622% |
| ImmuCell Corporation | 11.96 Million USD | -12425.775% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 10.653% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -20389.928% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -53713.64% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -3226.266% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -3372.974% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -3214.281% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -3008.603% |
| Vaxxinity, Inc. | 15.16 Million USD | -9784.283% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | -76.65% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -145826.7% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -10562447.555% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -6958.939% |
| Senti Biosciences, Inc. | 37.66 Million USD | -3880.375% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -923554.331% |
| Apollomics, Inc. | 4.66 Million USD | -32065.801% |
| 89bio, Inc. | 27.1 Million USD | -5430.648% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -1201.758% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -332644.007% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -21609.354% |
| Ardelyx, Inc. | 55.98 Million USD | -2578.089% |
| Pluri Inc. | 29.61 Million USD | -4962.974% |
| Prothena Corporation plc | 11.83 Million USD | -12567.917% |
| Pulmatrix, Inc. | 8.75 Million USD | -17022.522% |
| Celularity Inc. | 65.41 Million USD | -2191.832% |
| MeiraGTx Holdings plc | 89.26 Million USD | -1579.566% |
| Omeros Corporation | 338.28 Million USD | -343.196% |
| Ainos, Inc. | 5.96 Million USD | -25040.168% |
| Humacyte, Inc. | 58.1 Million USD | -2480.195% |
| Mesoblast Limited | 118.92 Million USD | -1160.688% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -80809.228% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -30641.193% |
| Blueprint Medicines Corporation | 774.12 Million USD | -93.671% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -29777.401% |
| Summit Therapeutics Inc. | 106.09 Million USD | -1313.065% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -2325.261% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -1199.783% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -4652.275% |
| Cytokinetics, Incorporated | 755.77 Million USD | -98.373% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -11101.793% |
| Nutriband Inc. | 241.28 Thousand USD | -621259.803% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -27323.596% |
| Roivant Sciences Ltd. | 499.74 Million USD | -200.0% |
| Evogene Ltd. | 1.13 Million USD | -131644.112% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -122187.765% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -2717652.198% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 13.828% |
| BioLineRx Ltd. | 11.59 Million USD | -12834.587% |
| Atai Life Sciences N.V. | 16.47 Million USD | -8999.587% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -70619.245% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -1436.005% |
| MediciNova, Inc. | 215.92 Thousand USD | -694234.17% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -59990.1% |
| MiMedx Group, Inc. | 48.09 Million USD | -3017.005% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -261.242% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -41661.783% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -91597.125% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -1835414.202% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -16265.55% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -10119.126% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -5368.714% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -12130.772% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -11888.23% |
| Allakos Inc. | 41.46 Million USD | -3515.695% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -13754.986% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -992779.47% |
| BioAtla, Inc. | 2.46 Million USD | -60845.041% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -1476.148% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -26932.961% |
| Precigen, Inc. | 7.09 Million USD | -21025.095% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| XOMA Corporation | 124.45 Million USD | -1104.699% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -7818.703% |
| Incyte Corporation | 38.28 Million USD | -3815.815% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -3373.135% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -13360.657% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -528.268% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -5656.818% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -429483.954% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -459097.594% |
| UroGen Pharma Ltd. | 100.21 Million USD | -1396.046% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -720.386% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -432780.794% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -491456.721% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -21834.865% |
| Chimerix, Inc. | 2.14 Million USD | -69827.612% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -4116.669% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -868158.5% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -5554.766% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 47 Thousand USD | -3189789.362% |
| OncoCyte Corporation | 2.86 Million USD | -52156.814% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -115296.362% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -7022138.876% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -995720.769% |
| Purple Biotech Ltd. | 351 Thousand USD | -427036.182% |
| NextCure, Inc. | 6.6 Million USD | -22598.683% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 97.89 Million USD | -1431.501% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -28560.83% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -554.148% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -154780.992% |
| NLS Pharmaceutics AG | 1.63 Million USD | -91667.509% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 280.63 Million USD | -434.234% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Curis, Inc. | 2.79 Million USD | -53559.556% |
| Daré Bioscience, Inc. | 5.31 Million USD | -28091.183% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -265253.628% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 44.95 Million USD | -3234.923% |
| BeiGene, Ltd. | 930.18 Million USD | -61.177% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -9546.119% |
| Alector, Inc. | 38.91 Million USD | -3752.325% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -131297.721% |
| Erasca, Inc. | 55.85 Million USD | -2583.986% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 19.55 Million USD | -7566.043% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -5766.521% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -382359.273% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | -32.223% |
| Histogen Inc. | 4.62 Million USD | -32337.213% |
| Fortress Biotech, Inc. | 88.59 Million USD | -1592.306% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -15117.702% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -2273.467% |
| Galecto, Inc. | 249 Thousand USD | -602007.631% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -132.49% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -978.363% |
| Molecular Templates, Inc. | 12.23 Million USD | -12158.774% |
| PDS Biotechnology Corporation | 23.85 Million USD | -6185.729% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -35284.659% |
| Amarin Corporation plc | 8.73 Million USD | -17059.757% |
| TG Therapeutics, Inc. | 110.79 Million USD | -1253.173% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -27679.285% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -58879.072% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -7852.305% |
| Onconetix, Inc. | 9.88 Million USD | -15065.715% |
| MacroGenics, Inc. | 33.97 Million USD | -4313.317% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -105555.25% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Adagene Inc. | 22.3 Million USD | -6621.014% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -613.449% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -13585.513% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -7288.006% |
| SciSparc Ltd. | 76 Thousand USD | -1972594.737% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -1727.976% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -455598.48% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -5826.35% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -628.087% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -2704.115% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 44.113% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -19479.082% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -2379658.73% |
| 2seventy bio, Inc. | 256.67 Million USD | -484.108% |
| Clene Inc. | 32.16 Million USD | -4561.696% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -68202.87% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -735146.259% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -17091.24% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Absci Corporation | 15.95 Million USD | -9295.551% |
| XBiotech Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -8618.079% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -5477.352% |
| Entera Bio Ltd. | 390 Thousand USD | -384322.564% |
| Trevena, Inc. | 35.23 Million USD | -4155.238% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -5841.145% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -5354.786% |
| INmune Bio, Inc. | 10.43 Million USD | -14264.741% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -311435.289% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -22979.557% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -3656602.439% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -5454.828% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -299209.048% |
| Jaguar Health, Inc. | 35.86 Million USD | -4080.837% |
| Clearside Biomedical, Inc. | 43 Million USD | -3386.542% |
| NexImmune, Inc. | 68.8 Thousand USD | -2178754.51% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -322318.925% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -122364.97% |
| Kronos Bio, Inc. | 28.27 Million USD | -5202.943% |
| Innoviva, Inc. | 449.07 Million USD | -233.852% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -211.796% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 44.532% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -7315.045% |
| Verastem, Inc. | 41.55 Million USD | -3507.691% |
| ProKidney Corp. | 4.41 Million USD | -33873.442% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -96314.662% |
| Imunon, Inc. | 1.62 Million USD | -92177.656% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -118887.937% |
| Statera Biopharma, Inc. | 16.26 Million USD | -9119.822% |
| ImmunityBio, Inc. | 883.67 Million USD | -69.66% |
| Korro Bio, Inc. | 33.2 Million USD | -4414.855% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -270.382% |
| Kineta, Inc. | 1.31 Million USD | -113738.117% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -42049.227% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -26614.306% |
| GT Biopharma, Inc. | 58 Thousand USD | -2584810.345% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -10279.729% |
| Celularity Inc. | 65.41 Million USD | -2191.832% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -2798.33% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cibus, Inc. | 24.62 Million USD | -5989.306% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -2012.331% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -1258.531% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -391348.564% |
| Kodiak Sciences Inc. | 181.63 Million USD | -725.432% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -1340.255% |
| Annexon, Inc. | 31.35 Million USD | -4681.528% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -1898.038% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -63915.713% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -21574.83% |
| Moderna, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -10724.895% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | -3.145% |
| Vor Biopharma Inc. | 35.66 Million USD | -4104.285% |
| Eyenovia, Inc. | 16.1 Million USD | -9207.614% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -374712.0% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -1244.738% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -3156.474% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -4567.937% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -152107.919% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -2520.834% |
| Immunocore Holdings plc | 84.03 Million USD | -1684.139% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -3752.127% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -1987.886% |
| Alkermes plc | 290.73 Million USD | -415.684% |
| Arcellx, Inc. | 97.62 Million USD | -1435.721% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -61068.929% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -3175.398% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -2306435.385% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -48231.657% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -118790.937% |
| Moolec Science SA | 2.64 Million USD | -56576.151% |
| Biomea Fusion, Inc. | 10.29 Million USD | -14461.461% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Geron Corporation | 85.89 Million USD | -1645.361% |
| Mereo BioPharma Group plc | 5.95 Million USD | -25088.978% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -3194.327% |
| Royalty Pharma plc | 6.13 Billion USD | 75.564% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -62316.653% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -89890.876% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -1300720.796% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -4331.711% |
| Humacyte, Inc. | 58.1 Million USD | -2480.195% |
| Structure Therapeutics Inc. | 5.45 Million USD | -27393.998% |
| NLS Pharmaceutics AG | 1.63 Million USD | -91667.509% |
| Genelux Corporation | 2.51 Million USD | -59417.586% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -1866307.728% |
| aTyr Pharma, Inc. | 15.09 Million USD | -9832.083% |
| Notable Labs, Ltd. | 2.04 Million USD | -73069.741% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -498462.754% |
| Mustang Bio, Inc. | 2.49 Million USD | -59917.934% |
| Immunovant, Inc. | 138 Thousand USD | -1086311.594% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -91781.169% |
| Vericel Corporation | 88.14 Million USD | -1600.927% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 29.22 Million USD | -5030.194% |
| Orgenesis Inc. | 22.62 Million USD | -6527.682% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -32428.705% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -738445.813% |
| GH Research PLC | 343 Thousand USD | -436998.542% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -7156.415% |
| PepGen Inc. | 20.1 Million USD | -7357.461% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -261093.031% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -1484303.96% |
| Belite Bio, Inc | 886 Thousand USD | -169115.35% |
| Pharming Group N.V. | 171.54 Million USD | -773.968% |
| XOMA Corporation | 124.45 Million USD | -1104.699% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -153985.098% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -525.683% |
| Xencor, Inc. | 83.43 Million USD | -1696.927% |
| Replimune Group, Inc. | 75.86 Million USD | -1876.101% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -6928.494% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -15842.663% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Turnstone Biologics Corp. | 3.21 Million USD | -46547.418% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -8808.188% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -61929.293% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -118790.937% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -1326668.142% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -145175.969% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -47359.576% |
| scPharmaceuticals Inc. | 40.26 Million USD | -3623.082% |
| HilleVax, Inc. | 51.19 Million USD | -2828.619% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -2691.48% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -16409.724% |
| Immunic, Inc. | 1.33 Million USD | -112287.406% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Aptorum Group Limited | 3.36 Million USD | -44488.667% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -371921.836% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -16409.724% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -70074.762% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -8860.899% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -69632.465% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -236.865% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -517519.276% |
| bluebird bio, Inc. | 330.32 Million USD | -353.869% |
| DBV Technologies S.A. | 14.38 Million USD | -10325.2% |
| Compugen Ltd. | 1.35 Million USD | -110873.205% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Peak Bio, Inc. | 10.72 Million USD | -13883.165% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -59821.982% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -24050.258% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -88770.658% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -3405.701% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -32183.549% |
| Benitec Biopharma Inc. | 284 Thousand USD | -527804.225% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -1673.104% |
| Adicet Bio, Inc. | 20.92 Million USD | -7065.207% |
| Prime Medicine, Inc. | 13.63 Million USD | -10897.198% |
| Aditxt, Inc. | 18.21 Million USD | -8129.493% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -1179.298% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -9697.086% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -185358.225% |
| PolyPid Ltd. | 11.77 Million USD | -12628.143% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -1539.275% |
| Invivyd, Inc. | 2.16 Million USD | -69149.33% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -42547087.214% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -2374.864% |
| CorMedix Inc. | 667.63 Thousand USD | -224462.034% |
| Instil Bio, Inc. | 86.05 Million USD | -1642.218% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -2858.731% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -676.04% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -4876.592% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -26947.592% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -11192.92% |
| AbCellera Biologics Inc. | 77.38 Million USD | -1837.514% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -1697.897% |
| Surrozen, Inc. | 3.37 Million USD | -44269.577% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -6008.907% |
| Verona Pharma plc | 51.32 Million USD | -2820.86% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -248531.509% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -1103.828% |
| Evaxion Biotech A/S | 10.86 Million USD | -13692.937% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -1901.479% |
| Shattuck Labs, Inc. | 4.2 Million USD | -35579.391% |
| AlloVir, Inc. | 27.42 Million USD | -5365.923% |
| BioVie Inc. | 6.11 Million USD | -24431.801% |
| Codexis, Inc. | 22.36 Million USD | -6603.845% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -165379.912% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -914259.597% |
| Agenus Inc. | 350.24 Million USD | -328.056% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -668311.948% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -639317.241% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -7022.995% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -7610.198% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Celcuity Inc. | 37.44 Million USD | -3903.73% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -69664.914% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -5162.92% |
| IN8bio, Inc. | 4.89 Million USD | -30540.67% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -111951.42% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -1313.531% |
| Liquidia Corporation | 3.5 Million USD | -42698.972% |
| Quantum-Si incorporated | 15.3 Million USD | -9697.086% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -1835414.202% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -13650.784% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -90598.609% |
| United Therapeutics Corporation | 700 Million USD | -114.178% |
| Solid Biosciences Inc. | 26.26 Million USD | -5608.159% |
| Immuneering Corporation | 4.46 Million USD | -33493.139% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -11192.92% |
| uniQure N.V. | 138.4 Million USD | -983.201% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -12985.869% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -1655.087% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -315531.158% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -11184.42% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -712169.05% |
| Cue Biopharma, Inc. | 14.69 Million USD | -10102.436% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -547070.803% |
| Zura Bio Limited | - USD | -Infinity% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -4874.775% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -152107.919% |
| Immunome, Inc. | 1.65 Million USD | -90763.515% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -86411.714% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -15232.87% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -4862.879% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -414056.906% |
| Altimmune, Inc. | 671 Thousand USD | -223334.873% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -2795.699% |
| Rallybio Corporation | 392 Thousand USD | -382361.224% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -35758.598% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -256181.709% |
| Moolec Science SA | 2.64 Million USD | -56576.151% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -361164.578% |
| NeurAxis, Inc. | 224.26 Thousand USD | -668431.169% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | -145.389% |
| Lumos Pharma, Inc. | 6.58 Million USD | -22667.623% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -15232.87% |
| 180 Life Sciences Corp. | 1.32 Million USD | -113473.457% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -7425.968% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -8677.736% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -96314.662% |
| Nutriband Inc. | 241.28 Thousand USD | -621259.803% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -181407.022% |
| argenx SE | 20 Million USD | -7396.24% |
| Neurogene Inc. | 16.25 Million USD | -9123.304% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -386.545% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -5152.962% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| AnaptysBio, Inc. | 17.81 Million USD | -8316.122% |
| Design Therapeutics, Inc. | 3.05 Million USD | -49055.672% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -572132.061% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -10437.307% |
| Achilles Therapeutics plc | 4.61 Million USD | -32386.414% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -1055708.451% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -14579.8% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -301.168% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -4881.056% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -40443.6% |
| Palisade Bio, Inc. | 369 Thousand USD | -406200.271% |
| Beam Therapeutics Inc. | 173.17 Million USD | -765.752% |
| AEON Biopharma, Inc. | 278 Thousand USD | -539197.842% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -447436.716% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -1402495.167% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -1876.283% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -2353.48% |
| Athira Pharma, Inc. | 1.58 Million USD | -94489.779% |
| Vaccinex, Inc. | 247 Thousand USD | -606882.996% |
| HCW Biologics Inc. | 6.45 Million USD | -23137.753% |
| XOMA Corporation | 124.45 Million USD | -1104.699% |
| Nektar Therapeutics | 230.4 Million USD | -550.712% |
| Arvinas, Inc. | 3.4 Million USD | -43995.529% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -91781.169% |
| Merus N.V. | 12.16 Million USD | -12227.315% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -1067.384% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -10753.106% |
| Rezolute, Inc. | 2.22 Million USD | -67191.203% |
| Clene Inc. | 32.16 Million USD | -4561.696% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -856353.76% |
| BeyondSpring Inc. | 3.99 Million USD | -37428.11% |
| Synlogic, Inc. | 17.27 Million USD | -8578.715% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -115226.769% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -4283465.714% |
| Peak Bio, Inc. | 10.72 Million USD | -13883.165% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -2787.445% |
| Krystal Biotech, Inc. | 8.09 Million USD | -18422.958% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -746.956% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -21144.835% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -1097494.331% |
| MannKind Corporation | 382.37 Million USD | -292.084% |
| Ikena Oncology, Inc. | 10.73 Million USD | -13862.079% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -366464.303% |
| Gossamer Bio, Inc. | 212.46 Million USD | -605.648% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -861536.782% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -16265.55% |
| Legend Biotech Corporation | 328.67 Million USD | -356.153% |
| Mural Oncology plc | 15 Million USD | -9888.993% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -3061.236% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -71258.782% |
| Champions Oncology, Inc. | 7.43 Million USD | -20078.304% |
| REGENXBIO Inc. | 89.29 Million USD | -1579.077% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -175312.807% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -271020.579% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -27592.058% |
| Vaxart, Inc. | 26.51 Million USD | -5554.552% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -9475.356% |
| Cellectis S.A. | 92.85 Million USD | -1514.647% |
| Longeveron Inc. | 2.04 Million USD | -73356.541% |
| Repare Therapeutics Inc. | 3.41 Million USD | -43866.217% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | -7.334% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -3117.823% |
| Revolution Medicines, Inc. | 87.94 Million USD | -1604.776% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -866517.341% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -37826.84% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -472848.896% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -856613.143% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | -85.459% |
| Denali Therapeutics Inc. | 52.24 Million USD | -2769.868% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -10307.496% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -109015.575% |
| Cingulate Inc. | 3.13 Million USD | -47721.393% |
| Passage Bio, Inc. | 26.29 Million USD | -5601.864% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -22394.344% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -367362.745% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -167601.119% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -1604.776% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -7191.708% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -118887.937% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -61065.809% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -47906.66% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -184764.118% |
| OmniAb, Inc. | 25.56 Million USD | -5765.373% |
| Anew Medical, Inc. | 1.6 Million USD | -93311.09% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -4967.961% |
| Lipocine Inc. | 17.16 Thousand USD | -8733722.673% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -12782.351% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -4229.583% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -25280.617% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -2522.301% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -738445.813% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -28927.067% |
| Ocugen, Inc. | 6.94 Million USD | -21499.885% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -10511.14% |
| Q32 Bio Inc. | 1.31 Million USD | -113651.745% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -223002.381% |
| Alumis Inc. Common Stock | 32.58 Million USD | -4501.743% |
| Equillium, Inc. | 824 Thousand USD | -181847.573% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -16413.361% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -498310.271% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -884.411% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -2831.769% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -193339.374% |
| Dominari Holdings Inc. | 3.02 Million USD | -49412.814% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -1586624.1% |
| vTv Therapeutics Inc. | 529 Thousand USD | -283311.72% |
| Bio-Techne Corporation | 419.53 Million USD | -257.357% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -1982.405% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -674.541% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -8777.594% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -6486.627% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -24648.234% |
| Nkarta, Inc. | 88.33 Million USD | -1597.153% |
| BioCardia, Inc. | 1.31 Million USD | -113911.255% |
| Iterum Therapeutics plc | 19.5 Million USD | -7584.904% |